Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Claudia Clavijo to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Claudia Clavijo has written about Dose-Response Relationship, Drug.

 
Connection Strength
 
 
 
0.051
 
  1. Elkomy MH, Sultan P, Carvalho B, Peltz G, Wu M, Clavijo C, Galinkin JL, Drover DR. Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome. Clin Pharmacol Ther. 2015 Feb; 97(2):167-76.
    View in: PubMed
    Score: 0.020
  2. Atkinson Ralls L, Drover DR, Clavijo CF, Carvalho B. Prior epidural lidocaine alters the pharmacokinetics and drug effects of extended-release epidural morphine (DepoDurĀ®) after cesarean delivery. Anesth Analg. 2011 Aug; 113(2):251-8.
    View in: PubMed
    Score: 0.016
  3. Steudel W, Dingmann C, Zhang YL, Bendrick-Peart J, Clavijo C, Shulze J, Betts R, Christians U. Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals. J Clin Pharmacol. 2011 Jan; 51(1):29-39.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)